Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

CUSIP: 83086J200

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
33,945,050
Total 13F shares
24,496,645
Share change
+22,450,365
Total reported value
$196,252,371
Put/Call ratio
100%
Price per share
$8.01
Number of holders
62
Value change
+$179,861,577
Number of buys
58

Quarterly Holders Quick Answers

What is CUSIP 83086J200?
CUSIP 83086J200 identifies SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q2 2024

As of 30 Jun 2024, Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,496,645 shares. The largest 10 holders included 5AM Venture Management, LLC, Versant Venture Management, LLC, Altium Capital Management LP, Logos Global Management LP, SPHERA FUNDS MANAGEMENT LTD., BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, CVI Holdings, LLC, and Driehaus Capital Management LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.